LIQUIDIA CORPORATION Shareholders' Equity
LIQUIDIA CORPORATION (LQDA) had Shareholders' Equity of $195.11 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $195.11M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $108.58M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $44.75M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $22.05M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $195.11M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $108.58M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $44.75M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $22.05M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $15.19M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $49.71M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $79.38M 10-Q · filed 2026-08-12 | $77.28M 10-K · filed 2025-03-19 |
| 2024-09-30 | $112.76M 10-Q · filed 2025-11-03 | $110.52M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $72.84M 10-Q · filed 2025-11-03 | $62.72M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $97.11M 10-Q · filed 2025-11-03 | $86.26M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $47.29M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $48.01M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $60.66M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $81.64M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $90.42M 10-K · filed 2026-03-05 | |
| 2022-09-30 | $95.03M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $102.11M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $55.39M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $65.27M 10-K · filed 2024-03-13 | $65.27M 10-K · filed 2022-03-17 |
| 2021-09-30 | $72.96M 10-Q · filed 2022-11-08 | $72.96M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $79.02M 10-Q · filed 2022-11-08 | $79.02M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $62.91M 10-Q · filed 2022-11-08 | $62.91M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $71.09M 10-K · filed 2023-03-20 | $71.09M 10-K · filed 2021-03-25 |
| 2020-09-30 | $65.28M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $8.87M 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $21.77M 10-Q · filed 2021-11-03 | |
| 2019-12-31 | $34.95M 10-K · filed 2022-03-17 | |
| 2018-12-31 | $18.69M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |